skip to content »

Translational Biology & Molecular Medicine

Houston, Texas

Benchtop, Research, Bedside and Application
Translational Biology & Molecular Medicine Graduate Program
not shown on screen

George D. Ferry, M.D.

George D. Ferry

Professor
Department of Pediatrics - Gastroenterology, Hepatology and Nutrition
Chief of Inflammatory Bowel Disease Clinic

Phone: 832-822-3602
Fax: 832-825-3633
E-Mail: gferry@bcm.edu

Education

  • M.D., Baylor College of Medicine, Houston, TX
  • Residency, Pediatrics, Baylor College of Medicine Affiliated Hospitals, Houston, TX
  • Fellowship, Gastroenterology, Departments of Medicine and Pediatrics, The Johns Hopkins Hospital, Baltimore, MD

Research Interest

  • Inflammatory bowel disease

Clinical Focus

  • Inflammatory bowel disease
  • Gastroesophageal reflux
  • Abdominal pain

Selected Publications

  • Hyams J, Crandle W, Kugathasan S, Griffiths A, Olson A, Johanns J, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Balsassano R, REACH Study Group. Introduction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology. 2007. 132:863-73.
  • Gupta N, Cohen SA, Bostrom AG, Kirschner BS, Baldassano RN, Winter HS, Ferry GD, Smith T, Abramson O, Gold BD, Heyman MB. Risk factor for initial surgery in pediatric patients with Crohn's disease. Gastroenterol. 2006. 130:1069-77.
  • Bousvaros A, Guandaline S, Baldassano RN, Botelho C, Evans J, Ferry GD, Goldin B, Hartigan L, Kutathasan S, Levy J, Murray KF, Oliva-Hemker M, Rosh JR, Tolia V, Zholudev A, Vanderhoof JA, Hibberd PL. (2005). A randomized double-blind trial of lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis. 2005. 11:833-9.
  • Griffiths AM, Otley AR, Hyams J, Quiros AR, Grand RJ, Bousvaros A, Feagan BG, Ferry GD. A review of activity indices and end points for clinical trials in children with Crohn's disease. Inflamm Bowel Dis. 2005. 11:185-96.
  • Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, Winter HS, Fain P, King C, Smith T, El-Serag HB. Children with early-onset inflammatory bowel disease (IBD): analysis of pediatric IBD consortium registry. J Pediatr. 2005. 146:35-40.
  • Jacobstein DA, Markowitz JE, Kirschner BS, Ferry GD, Cohen SA, GOLD BD, Winter HS, Heyman MB, Baldassano RN. Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium. Inflamm Bowel Dis. 2005. 11:442-6.
  • Baldassano R, Ferry G, Griffiths A, Mack D, Markowitz J, Winter H. Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2002. 34(3):245-8.

E-mail this page to a friend